These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2117810)

  • 21. Immunologic monitoring after organ transplantation: relationship between Epstein-Barr virus infection and CD19+ B cells measured by flow cytometry.
    Morrissey PE; Lorber KM; Marcarelli M; Bia MJ; Kliger AS; Lorber MI
    Transplant Proc; 1995 Feb; 27(1):1428-30. PubMed ID: 7533384
    [No Abstract]   [Full Text] [Related]  

  • 22. The Leu-2+7+ cell subset as a marker of immune activation in renal transplant recipients.
    Brando B; Civati G; Busnach G; Broggi ML; Belli LS; Brunati C; Seveso M; Sommaruga E; Minetti L
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1611-2. PubMed ID: 2484095
    [No Abstract]   [Full Text] [Related]  

  • 23. In situ antigenic modulation of human graft-infiltrating T cells is induced by OKT3 treatment.
    Caillat-Zucman S; Legendre C; Noel LH; Bach JF; Kreis H; Chatenoud L
    Transplant Proc; 1990 Aug; 22(4):1782. PubMed ID: 2143860
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of acute rejection of renal allografts with antithymocyte globulin or high-dosage prednisone. Influence of recipient DRw6 and DR matching.
    Hoitsma AJ; Van Lier HJ; Reekers P; Koene RA
    Neth J Med; 1985; 28(6):239-42. PubMed ID: 3892324
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes in peripheral blood lymphocyte patterns during early acute liver rejection: B cell increase as an index of rejection.
    Charco R; Máñez R; Caragol I; Llopart L; Español T; Margarit C
    Transplant Proc; 1992 Feb; 24(1):146. PubMed ID: 1539215
    [No Abstract]   [Full Text] [Related]  

  • 26. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depletion of CD8+ cells exacerbates organ-specific autoimmune diseases induced by CD4+ T cells in semiallogeneic hosts with MHC class II disparity.
    Saitoh T; Ikarashi Y; Ito S; Watanabe H; Fujiwara M; Asakura H
    J Immunol; 1990 Nov; 145(10):3268-75. PubMed ID: 2121823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
    Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
    Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow-cytometric monitoring of ATG therapy for steroid-resistant rejection.
    Clark KR; Forsythe JL; Shenton BK; Lennard TW; Proud G; Taylor RM
    Transplant Proc; 1992 Feb; 24(1):315. PubMed ID: 1531714
    [No Abstract]   [Full Text] [Related]  

  • 30. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
    Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M
    Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The OKT3 immunosuppressive effect. In situ antigenic modulation of human graft-infiltrating T cells.
    Caillat-Zucman S; Blumenfeld N; Legendre C; Noel LH; Bach JF; Kreis H; Chatenoud L
    Transplantation; 1990 Jan; 49(1):156-60. PubMed ID: 2137271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid immunodiagnosis of kidney rejection by using activation markers on kidney tubular cells and infiltrating T subset cells.
    Tötterman TH; Hanås E; Larsson E; Lindgren PG; Sjöberg O; Wahlberg J; Tufveson G
    Transplant Proc; 1987 Oct; 19(5):3570-1. PubMed ID: 3313860
    [No Abstract]   [Full Text] [Related]  

  • 33. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine.
    Knight RJ; Kerman RH; Podder H; Katz SM; Van Buren CT; Kahan BD
    Transplant Proc; 2005 Mar; 37(2):1280-2. PubMed ID: 15848695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic antilymphocyte globulin and HLA-DR matching reduce the incidence of rejection after cadaveric kidney transplantation.
    Weimar W; Hendriks GF; Wenting GJ; Vincent HH; Schreuder GM; Jeekel J
    Transplant Proc; 1987 Oct; 19(5):3612-3. PubMed ID: 3313869
    [No Abstract]   [Full Text] [Related]  

  • 35. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring.
    Abouna GM; al-Abdullah IH; Kelly-Sullivan D; Kumar MS; Loose J; Phillips K; Yost S; Seirka D
    Transplantation; 1995 Jun; 59(11):1564-8. PubMed ID: 7778170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killer cell subsets and alloresponsiveness in renal allograft recipients.
    Shabtai M; Waltzer WC; Pullis CK; Raisbeck AP; Malinowski K; Rapaport FT
    Transplant Proc; 1990 Aug; 22(4):1846-8. PubMed ID: 2143863
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunosuppressive and nonimmunosuppressive rabbit antihuman T-lymphocyte antibodies exhibit different recognition patterns to T-cell membrane antigens.
    Rebellato LM; Verbanac KM; Carver FM; Thomas JM
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1117-9. PubMed ID: 1824890
    [No Abstract]   [Full Text] [Related]  

  • 38. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase.
    Piras F; Colombari R; Minerba L; Murtas D; Floris C; Maxia C; Corbu A; Perra MT; Sirigu P
    Cancer; 2005 Sep; 104(6):1246-54. PubMed ID: 16078259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic monitoring with Orthoclone OKT3 therapy.
    Schroeder TJ; First MR; Hurtubise PE; Marmer DJ; Martin DM; Mansour ME; Melvin DB
    J Heart Transplant; 1989; 8(5):371-80. PubMed ID: 2529358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
    Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
    J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.